NCT03710083View on ClinicalTrials.gov

A Pivotal Study to Evaluate Guardian™ Connect CGM System Performance in China

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

July 25, 2019

Study Completion Date

July 25, 2019

Conditions
Diabetes Mellitus
Interventions
DEVICE

Guardian™ Sensor (3)

Use two Guardian™ Sensor (3)s each connected to a Guardian™ Connect transmitter for approximately 7 days.

Trial Locations (3)

100700

The Seventh Medical Center of PLA General Hospital, Beijing

200233

Shanghai Sixth People's Hospital, Shanghai

310016

Sir Run Run Shaw Hospital, Hangzhou

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT03710083 - A Pivotal Study to Evaluate Guardian™ Connect CGM System Performance in China | Biotech Hunter | Biotech Hunter